Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 93935

3 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
February 07, 2024
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Mckesson Medical-Surgical Inc. Corporate Office

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

3 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 3

Rocuronium Bromide Injection, Preservative Free, 10 mg / mL, Multiple-Dose Vial 10 mL, Rx only, Mfg: Auromedics Pharma LLC, NDC 55150-226-10

D-0371-2024
Recall number
D-0371-2024
Initiated
February 07, 2024
Classification
Class II
Status
Terminated
Quantity
70 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
cGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations: Products were stored outside the drug label specifications.

Code information

1064081

Distribution pattern

Product was distributed to three direct accounts in NM, AZ and UT.

drug · product 2 of 3

Infuvite Adult Multiple vitamins injection, single-dose vial 5mL, Rx only, MFG: Baxter Healthcare Corp., NDC 54643-5649-01

D-0372-2024
Recall number
D-0372-2024
Initiated
February 07, 2024
Classification
Class II
Status
Terminated
Quantity
70 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
cGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations: Products were stored outside the drug label specifications.

Code information

519644

Distribution pattern

Product was distributed to three direct accounts in NM, AZ and UT.

drug · product 3 of 3

Bicillin L-A (Penicillin G Benzathine) 1.2, MMU / 2 mL Injection Prefilled Syringe 2 mL, Rx only, Mfg: Pfizer Pharmaceuticals, NDC 60793-0701-10

D-0373-2024
Recall number
D-0373-2024
Initiated
February 07, 2024
Classification
Class II
Status
Terminated
Quantity
70 vials

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
cGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations: Products were stored outside the drug label specifications.

Code information

567951

Distribution pattern

Product was distributed to three direct accounts in NM, AZ and UT.